Abstract
This editorial refers to 'Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMAN......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
